1 / 36

Overview

CRRT Prescription Akash Deep Director - PICU King ’ s College Hospital London Chair Renal/CRRT Section European Society of Pediatric and Neonatal Intensive Care (ESPNIC). 0. Overview. Vascath – Size , location Rates & Dose Blood flow Dialysis fluid Replacement fluid

Download Presentation

Overview

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CRRT PrescriptionAkash DeepDirector - PICU King’s College HospitalLondonChairRenal/CRRT SectionEuropean Society of Pediatric and Neonatal Intensive Care (ESPNIC) 0

  2. Overview Vascath – Size , location Rates & Dose Blood flow Dialysis fluid Replacement fluid Ultrafiltration rate Anticoagulation Drug Dose Suggested Not necessarily a recipe

  3. Is there a “typical” prescription? • CRRT for AKI or Sepsis or Liver failure • does the dose matter ? • Modality : Do you do convective or diffusive or both , does it matter? • Blood Flow rate: based upon the size of the child or what the vascular access can give you? • Anticoagulation – Which, when, dose, mode of delivery • Drug dosing – a perennial debate!!!!

  4. Essential steps in CRRT Prescription • Decide the Indication to start CRRT • PRESCRIBE: • VASCULAR ACCESS – Size Location • Haemofilter and appropriate Sized Blood line set • Priming Solution • Blood Flow • Modality /Dose – Replacement Fluid/Dialysis Fluid • Prescribe Fluid loss rate • Prescription of electrolyte corrections • Anticoagulation – Dose,Modality, Monitoring • Drug Dosing

  5. Blood flow rate • Qb • Age & weight – based • Promote circuit lifespan + patient stability: clots vs alarms • Highly access-dependent • Aim return access pressures ~ < 200 mmHg, no alarms • Start lower and increase by about 10 minutes (?) – 50% of target • and then go up 10% every 10 minutes till desired flow reached

  6. Blood flow rate • No set “perfect rates” • From 3 to ~10 ml/kg/min, depending on age though • we use minimum of 50 mls/min for newborns • Examples: • 0-10 kg: 25-50ml/min • 11-20kg: 80-100ml/min • 21-50kg: 100-150ml/min • >50kg: 150-180ml/min • Neonates 8 to 12 ml/kg/min • Children 4 to 8 ml/kg/min • Older 2 to 4 ml/kg/min. • Most not > 200 ml/min: not dangerous just not necessary Based on previously most commonly used machine

  7. Blood flow rate • May need to modify: • - Patient hemodynamics – initial and subsequent • which might change with CRRT • - Be aware of access and return pressure • - Visually inspect filter for clots • - Trans-membrane pressure – may need to increase blood flow

  8. Treatment Dose

  9. Dialysis and Replacement Fluid Rates: Clearance & Dose • Clearance mostly a function of: • Dialysis fluid flow rate (Qd) • Replacement fluid flow rate (Qr) • Molecular weight and sieving coefficient • Higher rates • = higher clearance for IEM, drug removal, severe high K • = more middle molecule clearance (CVVH/CVVHDF) • = more hypophosphatemia, kalaemia, magnesaemia • = more amino acid losses • = more drug clearance • = more work to change bags, give electrolyte infusions Qd + Qr (CVVHDF)

  10. Dialysis and Replacement Fluid Rates: Clearance & Dose Urea clearance ~ 30-40 ml/min/1.73msq • No well-defined right “dose” of clearance. • For CRRT: mostly expressed in terms of effluent(ml/kg) per hour “Standard” suggestion: Qd or Qr or Qd+Qr ~ 40-60 ml/kg/hour OR 2 to 2.5 liters/hr/1.73msq. Some do much higher: some machines as high as 8L/hour REALIZE: What you prescribe is not necessarily what the patient gets!! Time off circuit, microclots in filter over time, predilution

  11. Prescribed and Delivered therapy dose • Typically, therapy dose would be prescribed at 35 ml/kg/hr, in practice the delivered therapy dose was on average 8ml/kg/hr less. • Prescription should exceed that calculated to be adequate because of the known gap. • Why might we ‘lose’ significant amounts of therapy dose? • Recirculation in vascular access • High filtration fractions • Filter clogging and clotting • Troubleshooting skills • Changing of circuits • Filter down time Vesconi et al Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury Crit care 2009 13 (2);r57

  12. CVVH Qr = 300 ml/hour 10 kg child: 30 ml/kg/hr “clearance”OR ~ 0.26 msq: 2L/1.73msq/hour = 300 ml/hour CVVHDF Qd = 150ml/hour Qr = 150 ml/hour CVVHD Qd = 300 ml/hour

  13. 425 patients Endpoint = survival 15 days after D/C HF 146 UF rate 20ml/kg/hr survival significantly lower in this group compared to the others 139 UF rate 35ml/kg/hr p=0.0007 140 UF rate 45ml/kg/hr p=0.0013 Dialysis Dose and OutcomeRonco et al. Lancet 2000; 351: 26-30 Conclusions: • Minimum UF rates should be ~ 35 ml/kg/hr • Survivors had lower BUNs than non-survivors prior to commencement of hemofiltration

  14. ATN Study

  15. Randomised Evaluation of Normal vs Augmented Level Replacement (RENAL) Therapy ) • 1500 critically ill adults • CVVHDF • 25 ml/kg/hour • 40 ml/kg/hour Mortality at 28 days was similar in the higher-intensity and lower-intensity treatment groups (38.5% and 36.9%, respectively), and mortality at 90 days was the same (44.7%) in both groups.

  16. Does the dose of solution exposure per unit of time matter • These adult studies have failed to note a dose response curve of survival • These studies are flawed for IHD vs CRRT was compared and CRRT was both convective and diffusive

  17. So • If you start with a standard prescription • Eg • BFR 5-10 mls/kg/min (access dependent) • Membrane surface area proportional to patient body surface area • Decision of convective or diffusive at approx 2000-3000/mls/hr/1.73m2

  18. and • If the marker of your clearance is not achieved • E.g. • inadequate clearance of Urea, Ammonia, intoxicant, lactate • Then increase your solution exposure per unit of time • Maximize convective clearance before adding diffusive clearance • Consider increasing the BFR and increasing surface area of the membrane • Filter downtimes to be minimised

  19. Solutions • CVVHD – dialysis fluid for diffusive clearance • CVVH – replacement fluid: • replacing fluid you are removing to achieve solute • clearance by convection • CVVHDF – both • Priming solutions – Saline /blood prime • Anticoagulant solutions • Using these to correct metabolic abnormalities (remove) and • prevent treatment-related metabolic abnormalities (replace).

  20. Dialysis fluid? Replacement fluid? • Personal suggestion: use the same solution • If needed (e.g. alkalosis) can modify the replacement solution • Regulatory issues may hinder: • Replacement solution – saline, with additives

  21. Solutions: watch for errors! • Barletta et al, PediatrNephrol, 2006 • Survey: ICU, Nephrology, CRRT • 16/31 programs reported solution compounding errors with manually dispensed solutions • 2 deaths • 1 non lethal cardiac arrest • 6 seizures (hypo/hypernatremia) • 7 without complications

  22. Ultrafiltration/fluid removal Rates • No Study has identified effective, safe UF rates in Children. • General acceptance that 1-2ml/kg/hr is often safe (stable patient) • Choose UF rate to: • - balance input (e.g. boluses, citrate, calcium, etc) • - remove excess fluid over time • - “make room” for IV fluids and nutrition • - Also provides solute clearance by convection

  23. Ultrafiltration/fluid removal Rates • Fluid removal should be safe AND effective – no need to sacrifice one for other: • Frequent communication • Frequent reassessment (MD), Hourly reassessment (RN) • Know what the “usual hourly input is”: • IV fluids • Citrate & calcium • Nutrition (give!!) • Meds/infusions • Provide “rules” for removing “intermittent fluids” Be aware of the “outs” (tubes, urine, diarrhea) Decide desired DAILY fluid removal based on: • Haemodynamics • TOTAL severity of Fluid Overload

  24. SINGLE PASS Albumin dialysis -SPAD • Removes protein bound small substances: • e.g. copper/Wilson's, drugs, toxins of liver failure • Albumin live a scavenger • Dialysis: • albumin-containing solution across highly permeable membrane • 20% albumin NOT “added” to dialysis fluid bag- it sinks however • it is mixed with normal dialysate via 3 way tap -it's “single pass” • - bags are changed • Shouldn't affect sodium – may affect (reduce) other electrolytes Collins et al, Pediatr Nephrol, 2008 Askenazi et al, Pediatrics, 2004 Ringe, Pediatr Crit Care Med, 2011

  25. ANTICOAGULATION

  26. ANTICOAGULATION-Points to consider • Choice of anticoagulant • Dose • Route of delivery – systemic, into the circuit

  27. Anticoagulation • Heparin • Citrate • Prostacyclin

  28. Dosing and Route • Heparin – 10-20 U/kg/hour • Prostacyclin – 2-8 ng/kg/min • Citrate – separate protocol • All anticoagulants to be used pre-filter with post filter monitoring ( ACT in heparin, ionised Ca in citrate)

  29. Drug Dose Alteration • Drug dosing- important ( antibiotics, anticonvulsants, sedation, inotropes) • Hepatic failure + CRRT – Bigger issues • Based on: • Protein Binding Information • Volume of Distribution • Molecular Weight

  30. Drug Prescribing in Renal Failureedited by George Aronoff et al • Commonly carried text by pharmacists • http://www.kdp-baptist.louisville.edu/renalbook/ • New edition to come out soon • Recommendations for new drugs • IHD and CRRT recommendations • Pediatric recommendations (T bunchman)

  31. Summary • Blood flow: balance access/circuit life with tolerability • Solutions: Many choices • Know their content, regional rules, CRRT type used • Decide on desired flexibility • Decide what's best for your institution (volume, expertise) • Bicarbonate and calcium are most substantial differences • Be aware of errors – can be life threatening • Dialysis/replacement fluid rates: ie clearance dose • Balance desired clearance with undesired losses • 2-2.5 L/hour/1.73msq – suggested only • Ultrafiltration rate: • Frequent reassessment, team + targeted fluid removal decisions • Safety AND efficacy are feasible

  32. Acknowledgements • T Bunchman • pCRRT Foundation • CRRT team at King’s

More Related